Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Fourteen Day Safety of Low-Dose Tamoxifen in Patients With Chronic Hepatitis C Who Have Failed Standard Medical Therapy

This study has been completed.
Sponsor:
Information provided by:
Bader, Ted, M.D.
ClinicalTrials.gov Identifier:
NCT00749138
First received: September 4, 2008
Last updated: March 7, 2010
Last verified: March 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)